Evidence map›Paper›PMID 31703643›Full record

Observational studyBMC cancer2019

Less micrometastatic risk related to circulating tumor cells after endoscopic breast cancer surgery compared to open surgery.

Shichao Li, Wenting Yan, Xinhua Yang, Li Chen, Linjun Fan, Haoxi Liu, Kun Liu, Yi Zhang, Jun Jiang

Open access · goldAbstract readComparative StudyObservational Study
In one paragraph

Observational study in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. [Effectiveness of sequential method pure single-port lumpectomy-breast conserving surgery for early-stage breast cancer in different quadrants].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. EphA2 as a new target for breast cancer and its potential clinical application.International journal of clinical and experimental pathology · 2021
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shichao LiDepartment of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University (Third Military Medical University), Gaotanyan Street 29, Chongqing, 400038, China.
Wenting YanDepartment of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University (Third Military Medical University), Gaotanyan Street 29, Chongqing, 400038, China.
Xinhua YangBreast and Thyroid Disease Center, Third Affiliated Hospital of Chongqing Medical University, Triumphant Road, Yubei District, Chongqing, 401120, China.
Li ChenDepartment of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University (Third Military Medical University), Gaotanyan Street 29, Chongqing, 400038, China.
Linjun FanDepartment of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University (Third Military Medical University), Gaotanyan Street 29, Chongqing, 400038, China.
Haoxi LiuDepartment of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University (Third Military Medical University), Gaotanyan Street 29, Chongqing, 400038, China.
Kun LiuDepartment of Epidemiology, College of Preventive Medicine, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
Yi ZhangDepartment of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University (Third Military Medical University), Gaotanyan Street 29, Chongqing, 400038, China. zy53810@163.com.
Jun JiangDepartment of Breast and Thyroid Surgery, Southwest Hospital, Army Medical University (Third Military Medical University), Gaotanyan Street 29, Chongqing, 400038, China. jcbd@medmail.com.cn.ORCID http://orcid.org/0000-0002-8931-9872
Army Medical University · CNThird People 's Hospital of Chongqing · CN

Funding

Fund of Army Medical University (Third Military Medical University) 2010XLC03Fund of Army Medical University (Third Military Medical University) 2018YFC1707503
6 · The paper itself

Abstract

backgroundIncrease of circulating tumor cells (CTCs) has been found after surgery for various carcinomas but not confirmed for breast cancer, and whether endoscopic surgery confers identical effect to CTCs as open surgery did is not clear. The present study aimed to investigate whether CTCs increase after surgery and whether there is a difference between open surgery and endoscopic surgery.

methodsPre- and postoperative peripheral blood (5 mL) obtained from 110 female patients with operable breast cancer (53 underwent endoscopic surgery, 57 underwent open radical mastectomy). Quantitative real-time reverse transcription-PCR was done to detect cytokeratin 19 mRNA-positive CTC. CTC detection rate, cell number and the increase after surgery (named micrometastasis) were compared between the two groups.

resultsIn the open group, CTC positive rate before and after surgery were 22.81 and 33.33%; median CTC number before and after surgery were 0.21 and 0.43 and 17 patients (29.82%) had increased micrometastatic risk. In the endoscopic group, CTC positive rate before and after surgery were 24.53 and 28.30%; median CTC number before and after surgery were 0.27 and 0.36, and 8 patients (15.09%) had increased micrometastatic risk. There was a suggestive higher postoperative CTC detection rate and CTC number and a significant increased postoperation micrometastatic risk was observed in the open group compared to the endoscopic group (OR = 3.19, 95%CI: 1.05-9.65) after adjustment for clinicopathologic characteristics. DISCUSSION: CTC tends to increase in breast cancer patients after surgery, and the micrometastatic risk was higher for open surgery compared to endoscopic surgery.

trial registrationThis study was prospectively registered at Chinese Clinical Trial Register (ChiCTR-OCH-10000859, 24 April 2010).

Indexed as

Neoplasm MicrometastasisNeoplastic Cells, CirculatingAdultBlood Cell CountBreast NeoplasmsEndoscopyFemaleHumansKeratin-19MastectomyMiddle AgedPrognosisProspective StudiesReal-Time Polymerase Chain ReactionRiskRNA, MessengerKeratin-19KRT19 protein, humanRNA, MessengerBreast neoplasmsCirculating tumor cellsEndoscopic breast surgeryMicrometastasesNeoplastic cellsOpen surgery

Identifiers

PMID31703643
PMCPMC6842272
OpenAlexW2983937933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.